| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RenovoRx, Inc. | Chief Clinical Officer | Stock Option | 6.62K | Jul 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RNXT | RenovoRx, Inc. | Jul 1, 2025 | 1 | $0 | 4 | Jul 3, 2025 | Chief Clinical Officer |
| RNXT | RenovoRx, Inc. | Apr 14, 2025 | 1 | $0 | 4 | Apr 16, 2025 | Chief Clinical Officer |
| RNXT | RenovoRx, Inc. | Mar 6, 2024 | 1 | $0 | 4 | Mar 8, 2024 | Chief Clinical Officer |
| RNXT | RenovoRx, Inc. | Mar 1, 2024 | 0 | $0 | 3 | Mar 8, 2024 | Chief Clinical Officer |